Home » Newsletters » BioWorld Science

BioWorld Science

July 16, 1997

View Archived Issues

Dual mechanism of action for antiatherosclerotic compound Org-13061

Parke-Davis protein tyrosine kinase inhibitor has multiple activities

New carbapenem ester prodrug claimed by Nippon Lederle

Toyama claims antibacterial agents

Neurokinin antagonists developed at Zeneca

Agents with affinity for central cannabinoid receptors reported by Sanofi

Katayama's new cephems

New PLA2 inhibitors for inflammatory conditions

Cholecalciferols for leukemia prepared at Roche

Roussel Uclaf describes antiandrogenic compounds

Peptidomimetic protein farnesyltransferase inhibitors from Merck & Co.

New oral antidiabetic agents disclosed

Merck & Co. develops potent and selective pyridinone acetamide thrombin inhibitor

Mianserin studied for treatment of sexual dysfunction

SB-242084: a potent and selective 5-HT2C receptor antagonist

A new target for antiepileptic drugs

New antipsychotic agent goes head-to-head with established therapies

Intranasal flu vaccine effective and safe in children

Genesys Pharma receives Canadian approval to commence phase I trial with antisense AIDS treatment

Pharmacokinetics of nicotine carbomer enema evaluated in UC patients and volunteers

RiboGene signs marketing agreement for intranasal metoclopramide

Fujisawa comarkets Hokuriku's Ganaton

Regranex recommended for approval by FDA advisory committee

Senetek files third PLA for INVICORP

Texas Biotechnology initiates NDA filing for Novastan

Roberts acquires Searle manufacturing site

Sequus and Sam Yang sign marketing agreement for Amphocil

Roche rights to Viracept expanded

Once-daily atorvastatin vs. pravastatin for hypercholesterolemia

Athena Neurosciences and Wyeth-Ayerst copromote Naprelan

Long-acting benzodiazepines increase risk of car crashes in the elderly

Survival rates after radical prostatectomy estimated

RPR launches room-temperature formulation of DDAVP

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...